BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Bone cancer AND BIRC3, AIP1, 330, ENSG00000023445, HIAP1, Q13489, MIHC, CIAP2, API2, cIAP2, MALT2, hiap-1, RNF49, HAIP1
240 results:

  • 1. PGRN is involved in macrophage M2 polarization regulation through TNFR2 in periodontitis.
    Zhang L; Nie F; Zhao J; Li S; Liu W; Guo H; Yang P
    J Transl Med; 2024 Apr; 22(1):407. PubMed ID: 38689292
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Sclerosing Epithelioid Fibrosarcoma (SEF) versus Low Grade Fibromyxoid Sarcoma (LGFMS): Presentation and outcome in the nationwide NETSARC+ series of 330 patients over 13 years.
    Blay JY; Tlemsani C; Toulmonde M; Italiano A; Rios M; Bompas E; Valentin T; Duffaud F; Le Nail LR; Watson S; Firmin N; Dubray-Longeras P; Ropars M; Perrin C; Hervieu A; Lebbe C; Saada-Bouzid E; Soibinet P; Fiorenza F; Bertucci F; Boudou P; Vaz G; Bonvalot S; Honoré C; Marec-Berard P; Minard V; Cleirec M; Biau D; Meeus P; Babinet A; Dumaine V; Carriere S; Fau M; Decanter G; Gouin F; Ngo C; Le Loarer F; Karanian M; Meurgey A; Dufresne A; Brahmi M; Chemin-Airiau C; Ducimetiere F; Penel N; Le Cesne A;
    Eur J Cancer; 2024 Jan; 196():113454. PubMed ID: 38008029
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Clinical Predictors of Survival in Patients With BRAFV600-Mutated Metastatic Melanoma Treated With Combined BRAF and MEK Inhibitors After Immune Checkpoint Inhibitors.
    Kahn AM; Perry CJ; Etts K; Kluger H; Sznol M
    Oncologist; 2024 Apr; 29(4):e507-e513. PubMed ID: 37971411
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. The joint effects of physical activity and sleep duration on risk of osteoporosis in Taiwanese adult population: The Taiwan Biobank Study.
    Chen KH; Su CM; Liu WJ; Tzeng HE; Lee CL; Tsai CH
    Osteoporos Int; 2024 Mar; 35(3):523-531. PubMed ID: 37947843
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Cost-Effectiveness Modeling of Prostate-Specific Membrane Antigen Positron Emission Tomography with Piflufolastat F 18 for the Initial Diagnosis of Patients with Prostate cancer in the United States.
    Yee CW; Harvey MJ; Xin Y; Kirson NY
    Pharmacoeconomics; 2024 Feb; 42(2):231-247. PubMed ID: 37934376
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Multiplex immunohistochemistry elucidates increased distance between cytotoxic T cells and plasma cells in relapsed myeloma, and identifies Lag-3 as the most common checkpoint receptor on cytotoxic T cells of myeloma patients.
    Ninkovic S; Purton LE; Harrison SJ; Quach H
    Haematologica; 2024 May; 109(5):1487-1500. PubMed ID: 37855027
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. METTL3-mediated m6A modification of circRNF220 modulates miR-330-5p/survivin axis to promote osteosarcoma progression.
    Liu F; Li W; Jin Z; Ye J
    J Cancer Res Clin Oncol; 2023 Dec; 149(19):17347-17360. PubMed ID: 37838643
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Development of a novel 12-point grading system for evaluating epidural spinal cord compression and its clinical implications.
    Cao X; Jiang W; Zhao X; Yu H; Lei M; Cao Y; Su X; Liu Y
    Spine J; 2023 Dec; 23(12):1858-1868. PubMed ID: 37499881
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Treatment Refractoriness in Chronic Lymphocytic Leukemia: Old and New Molecular Biomarkers.
    Maher N; Mouhssine S; Matti BF; Alwan AF; Gaidano G
    Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373521
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Therapies for acute myeloid leukemia in patients ineligible for standard induction chemotherapy: a systematic review.
    Heuser M; Fernandez C; Hauch O; Klibanov OM; Chaudhary T; Rives V
    Future Oncol; 2023 Apr; 19(11):789-810. PubMed ID: 37170899
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Nuclear Export Inhibitors Selinexor (KPT-330) and Eltanexor (KPT-8602) Provide a Novel Therapy to Reduce Tumor Growth by Induction of PANoptosis.
    Camilli S; Lockey R; Kolliputi N
    Cell Biochem Biophys; 2023 Sep; 81(3):421-426. PubMed ID: 37126200
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Plasma hPG
    Prieur A; Harper A; Khan M; Vire B; Joubert D; Payen L; Kopciuk K
    BMC Cancer; 2023 Apr; 23(1):305. PubMed ID: 37016331
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Exploring the relationships between hormone receptor, HER2 status, and bone involvement in the first distant metastases of in Chinese breast cancer patients who lacked HER2 targeted therapy.
    Jia Z; Dai M; Shang Y; Li Y; Li Z
    BMC Cancer; 2023 Jan; 23(1):93. PubMed ID: 36703144
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Epiphyseal-sparing biological reconstruction of bone sarcoma in children: Focus on articular function and growth.
    Raux S; Ducrot C; Marec-Bérard P; Corradini N; Claude L; Dijoud F; Picard C; Bouhamama A; Chotel F
    Orthop Traumatol Surg Res; 2023 May; 109(3):103540. PubMed ID: 36592656
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. A novel nomogram to stratify quality of life among advanced cancer patients with spinal metastatic disease after examining demographics, dietary habits, therapeutic interventions, and mental health status.
    Li Y; Long Z; Wang X; Lei M; Liu C; Shi X; Liu Y
    BMC Cancer; 2022 Nov; 22(1):1205. PubMed ID: 36424551
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. [CircRNA circTNPO1 promotes the proliferation and metastasis of osteosarcoma by sponging miR-338-3p].
    Lu JH; Huang XW; Zhang GQ; Ma Y; Chen JX
    Zhonghua Zhong Liu Za Zhi; 2022 Sep; 44(9):968-974. PubMed ID: 36164699
    [No Abstract]    [Full Text] [Related]  

  • 17. Cross-cultural adaptation and validation of simplified Chinese version of the Spine Oncology Study Group Outcomes Questionnaire (SOSGOQ) 2.0 with its assessment in clinical setting.
    Yin M; Sun Z; Ding X; Wang T; Sun Y; Li L; Gao X; Ma J; Huang Q; Xiao J; Mo W
    Spine J; 2022 Dec; 22(12):2024-2032. PubMed ID: 36031097
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Chrysin sensitizes osteosarcoma cells against TRAIL-induced apoptosis.
    Xie B; Yang J; Zhang J
    Cell Biol Int; 2022 Nov; 46(11):1825-1833. PubMed ID: 35979647
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Head-to-head comparison of
    Huo H; Shen S; He D; Liu B; Yang F
    Prostate Cancer Prostatic Dis; 2023 Mar; 26(1):16-24. PubMed ID: 35931759
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Taxane monotherapy regimens for the treatment of recurrent epithelial ovarian cancer.
    Patel A; Kalachand R; Busschots S; Doherty B; Kapros E; Lawlor D; Hall N; Stordal BK
    Cochrane Database Syst Rev; 2022 Jul; 7(7):CD008766. PubMed ID: 35866378
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 12.